Loading clinical trials...

Consistency Lots Vaccine Study (V260-009) | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Consistency Lots Vaccine Study (V260-009)

Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants

NCT00092456•Merck Sharp & Dohme LLC

Summary

This study was designed to evaluate consistency in the antibody response to three manufactured lots of an investigational Rotavirus Vaccine.

Eligibility

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy infants

Exclusion Criteria

•History of abdominal disorders from a birth defect, intussusception, or abdominal surgery
•Known or suspected problems with the immune system
•Fever at time of immunization
•Prior administration of a rotavirus vaccine
•History of known prior rotavirus disease, chronic diarrhea, or failure to thrive.

Key Dates

Start Date

May 1, 2003

Primary Completion Date

August 1, 2004

Completion Date

August 1, 2004

Last Updated

October 5, 2015

Enrollment

793

ACTUAL participants

Conditions

Rotavirus Infections

Interventions

rotavirus vaccine, live, oral, pentavalent

BIOLOGICAL

Placebo

BIOLOGICAL

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

NCT06962904

Rotavirus Infections

View study

COMPLETEDPHASE2

A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine

NCT03483116

Rotavirus Infections

View study

COMPLETEDPHASE4

Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study

NCT02542462

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 5, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Consistency Lots Vaccine Study (V260-009)

Inclusion Criteria

Exclusion Criteria

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine

Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

ROTATEQ™ Post-Marketing Surveillance in the Philippines